Related Experiment Video
Updated: Oct 16, 2026

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
Apoptosis and chemoresistance in human ovarian cancer: is Xiap a determinant?
1Department of Obstetrics and Gynaecology and Department of Cellular and Molecular Medicine, University of Ottawa, Loeb Health Research Institute, The Ottawa Hospital (Civic Campus), Canada.
Abstract:
Cisplatin-induced apoptosis in epithelial ovarian cancer cells is in part a consequence of suppressed Xiap expression and upregulation of the Fas/FasL system. Changes in the expression of these 'cell death' and 'cell survival' genes lead to activation of caspase-3, and cleavage of MDM2 and FAK. Failure of cancer cells to maintain a balance in the expression of these genes in favor of apoptotic cell death may be an important factor of chemoresistance. Xiap may be a novel target for gene therapy of human ovarian epithelial cancer and, dependent on P53 status, expression of Xiap antisense alone or in combination with wild-type P53 sense may offer a new approach for the treatment of the chemoresistant cancer.
Insights
Cisplatin chemotherapy triggers apoptosis in ovarian cancer by altering cell death and survival gene expression. Targeting Xiap (X-linked inhibitor of apoptosis protein) may overcome chemoresistance.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Cisplatin is a key chemotherapy agent for epithelial ovarian cancer (EOC).
- Chemoresistance remains a significant challenge in EOC treatment.
- The balance between cell death and cell survival genes influences treatment response.
Purpose of the Study:
- To investigate the molecular mechanisms underlying cisplatin-induced apoptosis in EOC cells.
- To identify key regulatory genes involved in chemoresistance.
- To explore Xiap as a potential therapeutic target for overcoming cisplatin resistance.
Main Methods:
- Analysis of gene expression changes in EOC cells treated with cisplatin.
- Focus on the roles of Xiap (X-linked inhibitor of apoptosis protein), Fas/FasL, caspase-3, MDM2, and FAK.
- Exploration of gene therapy strategies involving Xiap antisense and P53.
Main Results:
- Cisplatin treatment suppresses Xiap expression and upregulates the Fas/FasL system in EOC cells.
- These changes activate caspase-3 and lead to cleavage of MDM2 and FAK.
- Imbalance in these gene expressions favors chemoresistance.
Conclusions:
- Suppressed Xiap and activated Fas/FasL are crucial in cisplatin-induced apoptosis.
- Xiap dysregulation contributes to chemoresistance in EOC.
- Targeting Xiap, potentially with P53 modulation, offers a novel therapeutic strategy for chemoresistant ovarian cancer.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Apoptosis
Treatment Resistant Cancers
The Extrinsic Apoptotic Pathway
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
